InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,859.85
(
0.00%
)
US TECH 100
19,893.20
(
-0.03%
)
Dow Jones
43,065.22
(
0.00%
)
Brent Oil
74.29
(
-0.83%
)
Bitcoin
65,941.05
(
-0.18%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

serano1

Send PM Follow Ignore
Followers 12
Posts 1021
Boards Moderated 0
Alias Born 06/07/2012

serano1

Re: None

Thursday, 02/14/2013 2:51:35 PM

Thursday, February 14, 2013 2:51:35 PM

Post# of 158400
Quote:
Drugmakers may win approval from U.S. regulators for “breakthrough” therapies after a single round of studies, rather than three, in an effort to speed them to patients, a Food and Drug Administration official said.


http://www.bloomberg.com/news/2013-02-11/innovative-drugs-may-win-u-s-approval-after-early-trials.html

This would be a great advantage
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up